<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04528303</url>
  </required_header>
  <id_info>
    <org_study_id>WGS_CODE_01</org_study_id>
    <nct_id>NCT04528303</nct_id>
  </id_info>
  <brief_title>Whole Genome Sequencing Versus Whole Exome Sequencing for Congenital Diarrhea and Enteropahty</brief_title>
  <official_title>A Randomized, Controlled Trial of the Effectiveness of Whole Genome Sequencing Versus Whole Exome Sequencing for Screening Patients With Congenital Diarrhea and Enteropathy (CODESeq)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital of Fudan University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will seek to determine if whole genome sequencing (WGS) improves diagnostic rates,&#xD;
      and outcomes for congenital diarrhea and enteropathy (CODE) patients. The investigator will&#xD;
      enroll 180 patients in a randomized controlled study to either WGS or whole exome sequencing&#xD;
      (WES). This study is designed to evaluate whether CODE patients would benefit from WGS guided&#xD;
      precision medicine.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic rates between WGS and WES</measure>
    <time_frame>Within approximately 60 days of enrollment</time_frame>
    <description>Diagnostic rate of genome and exome based on rate of clinically confirmed diagnoses.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients receiving precision medicine guided by sequencing results</measure>
    <time_frame>Within approximately 60 days of enrollment</time_frame>
    <description>Rate of application of precision medicine suggested by the results of WGS or WES.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality of patients</measure>
    <time_frame>Within approximately 1 year of enrollment</time_frame>
    <description>Mortality of patients after WGS and WES</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of parental satisfaction with sequencing</measure>
    <time_frame>Within one week of patient enrollment</time_frame>
    <description>Parental satisfaction with decision to pursue sequencing based on questionnaire survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of parents who are available for trio sequencing</measure>
    <time_frame>Within one week of patient enrollment</time_frame>
    <description>Number of subjects in which both parents are available for trio sequencing</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Diarrhea, Infantile</condition>
  <condition>Enteropathy</condition>
  <arm_group>
    <arm_group_label>Whole genome sequencing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Whole exome sequencing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Whole genome sequencing</intervention_name>
    <description>Genomic sequencing and molecular diagnostic results</description>
    <arm_group_label>Whole genome sequencing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Whole exome sequencing</intervention_name>
    <description>Genomic sequencing and molecular diagnostic results</description>
    <arm_group_label>Whole exome sequencing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with chronic diarrhea lasting greater than 2 months&#xD;
&#xD;
          -  Patients with consent from parents or legal guardians&#xD;
&#xD;
          -  Biological relative of a patient enrolled in this study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic diarrhea caused by specific infections, i.e. CMV, Clostridioides difficile&#xD;
&#xD;
          -  Chronic diarrhea with necrotizing enterocolitis, short bowel syndrome&#xD;
&#xD;
          -  Functional diarrhea&#xD;
&#xD;
          -  Patients with previously confirmed monogenic diarrhea&#xD;
&#xD;
          -  Patients with poor compliance&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>August 24, 2020</study_first_submitted>
  <study_first_submitted_qc>August 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2020</study_first_posted>
  <last_update_submitted>June 8, 2021</last_update_submitted>
  <last_update_submitted_qc>June 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Diarrhea, Infantile</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

